<DOC>
	<DOCNO>NCT00467558</DOCNO>
	<brief_summary>The goal propose study evaluate efficacy safety naltrexone compulsive sexual behavior . Twenty subject DSM-IV compulsive sexual behavior receive 8 week naltrexone placebo . The hypothesis test naltrexone effective reduce urge act sexually patient compulsive sexual behavior . The propose study provide need data treatment disable disorder currently lack clearly effective treatment .</brief_summary>
	<brief_title>Double-Blind Naltrexone Compulsive Sexual Behavior</brief_title>
	<detailed_description>The propose study consist 8 week treatment either naltrexone placebo 20 subject compulsive sexual behavior .</detailed_description>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1. men woman age 2175 ; 2. current diagnosis compulsive sexual behavior 1. unstable medical illness clinically significant abnormality prestudy laboratory test physical examination ; 2. history seizure ; 3. myocardial infarction within 6 month ; 4. current pregnancy lactation , inadequate contraception woman childbearing potential ; 5. clinically significant suicidality ; 6. current recent ( past 1 month ) DSMIV substance abuse dependence ; 7. illegal substance within 2 week study initiation ; 8. initiation psychotherapy behavior therapy mental health professional within 3 month prior study baseline ; 9. initiation psychotropic medication within 2 month prior study inclusion ; 10. previous treatment naltrexone ; 11. treatment investigational medication depot neuroleptic within 3 month , fluoxetine within 6 week , psychotropics within 2 week prior study baseline</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Impulse Control Disorder</keyword>
	<keyword>Compulsive Sexual Behavior</keyword>
</DOC>